Browsing "Pharmacology" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 427 to 446 of 918 < previous   next >
PreviewIssue DateTitleAuthor(s)
2008Ibudilast in healthy volunteers: Safety, tolerability and pharmacokinetics with single and multiple dosesRolan, P.; Gibbons, J.; He, L.; Chang, E.; Jones, D.; Gross, M.; Davidson, J.; Sanftner, L.; Johnson, K.
2009Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological diseaseRolan, P.; Hutchinson, M.; Johnson, K.
2021Identifying the core concepts of pharmacology educationNgo, S.; White, P.J.; Davis, E.A.; Santiago, M.; Angelo, T.; Shield, A.; Babey, A.-M.; Kemp-Harper, B.; Maynard, G.; Al-Sallami, H.S.; Musgrave, I.F.; Fernandes, L.B.; Hinton,, T.
2005Immunosuppressant drug monitoring: Is the laboratory meeting clinical expectations?Morris, R.
2003Immunosupressant drug monitoring - recent innovations with emphasis on cyclosporineMorris, R.; Holt, D.; Shaw, L.
2004Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansGlaeser, H.; Drescher, S.; Hofmann, U.; Heinkele, G.; Somogyi, A.; Eichelbaum, M.; Fromm, M.
2005Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal diseaseReuter, S.; Evans, A.; Faull, R.; Chace, D.; Fornasini, G.
2010Impact of NGO run mid day meal program on nutrition status and growth of primary school childrenSharma, A.; Singh, S.; Meena, S.; Kannan, A.
2015Impact on drug safety of variation in adherence: the need for routinely reporting measures of dose Intensity in medication safety studies using electronic health dataRoughead, E.E.; Pratt, N.L.
2017Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid-substitution patientsNewcombe, D.; Somogyi, A.; Bochner, F.; White, J.
2012Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependenceColler, J.; Hutchinson, M.
1995Improved efficacy with non-simultaneous administration of first doses of gentamicin and ceftazidime in vitroBarclay, Murray L.; Begg, Evan J.; Chalmers, Stephen T.; Boswell, D. Ross
1996Improvements in retention rates and changes in client groups with methadone maintenance streaming.White, J.; Ryan, C.; Ali, R.
2023In vitro and in vivo evaluation of diethyldithiocarbamate with copper ions and its liposomal formulation for the treatment of Staphylococcus aureus and Staphylococcus epidermidis biofilmsKaul, L.; Abdo, A.I.; Coenye, T.; Swift, S.; Zannettino, A.; Süss, R.; Richter, K.
2000In vitro covalent binding of Nafenopin-CoA to human liver proteinsSallustio, B.; Nunthasomboon, S.; Drogemuller, C.; Knights, K.
2004In vitro opioid induced proliferation of peripheral blood immune cells correlates with in vivo cold pressor pain tolerance in humans: a biological marker of pain toleranceHutchinson, M.; La Vincente, S.; Somogyi, A.
2021In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogensNguyen, H.T.; Venter, H.; Veltman, T.; Williams, R.; Anne O'Donovan, L.; Russell, C.C.; McCluskey, A.; Page, S.W.; Ogunniyi, A.D.; Trott, D.J.
2010In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humansRaungrut, P.; Uchaipichat, V.; Elliot, D.; Janchawee, B.; Somogyi, A.; Miners, J.
2007In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA) but not 3 4-methylenedioxymethamphetamine (MDMA) leads to long-lasting deficits in serotonin transporter functionCallaghan, P.; Owens, W.; Javors, M.; Sanchez, T.; Jones, D.; Irvine, R.; Daws, L.
2002In vivo and in vitro potency studies of 6b-naltrexol, the major human metabolite of naltrexonePorter, S.; Somogyi, A.; White, J.